MIT scientists have developed a groundbreaking technique to grow artificial blood vessels, marking a significant advancement in tissue engineering. This innovative approach, detailed in the Proceedings of the National Academy of Sciences, utilizes mechanical stretching to enhance the growth of capillary-like sprouts, offering a promising solution to the challenge of oxygen and nutrient delivery in engineered tissues. The research introduces a vessel-on-a-chip platform, employing magnets to apply controlled strain within a three-dimensional tissue model, allowing researchers to manipulate the growth direction and strength of blood vessels.
The device, smaller than a postage stamp, features a central hollow channel lined with human endothelial cells, which naturally form blood vessels. By stretching the vessel wall using an embedded magnetic actuator, the team observed increased sprouting and guided the direction of growth. The study revealed that dynamic stretching at 5% strain produced the most sprouts, while 15% strain resulted in longer vessels. This finding is particularly intriguing, as it suggests that the direction and strength of stretching can be precisely controlled to influence vessel development.
One of the key insights from this research is the role of mechanical cues in steering growing vessels. When the gel was stretched along one axis, sprouts preferentially grew along the same line, demonstrating the ability to direct vessel growth. This discovery has profound implications for tissue engineering, as it allows researchers to program blood vessel growth with physical cues, potentially enabling the fabrication of engineered tissues with organized vascular networks.
The study also explored the biological mechanisms underlying the response to mechanical stimulation. By examining the PIEZO1 gene, which controls pressure-sensitive ion channels in cell membranes, the researchers found that it contributes to strain-induced vessel growth. However, the barrier strengthening response was not entirely dependent on PIEZO1, indicating the involvement of other force-sensing pathways. RNA sequencing further supported a broader mechanical response, with dynamic strain altering hundreds of genes and enhancing pathways tied to angiogenesis and cell migration.
The practical implications of this research are far-reaching. Precisely guiding small blood vessels could overcome a significant barrier in tissue engineering, as existing methods struggle to create fine networks with controlled geometry. The magnetic platform offers a novel approach to adding physical instructions after tissue growth has begun, allowing researchers to manipulate vessel direction and strength over time. Future versions of the device may include additional cell types and flowing blood to better replicate native circulation, potentially leading to thicker and better-supplied implants.
In conclusion, MIT's breakthrough in growing artificial blood vessels opens up exciting possibilities for tissue engineering and medical advancements. The ability to precisely control vessel growth and direction could revolutionize the development of engineered tissues, offering hope for improved treatments for debilitating diseases and injuries. As the research progresses, we can anticipate further innovations in this field, bringing us closer to the realization of more realistic and functional laboratory models for studying diseases involving abnormal blood vessel growth.
